{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:21:27Z","timestamp":1793859687194,"version":"4.6.1"},"publisher-location":"Cham","reference-count":64,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319643694","type":"print"},{"value":"9783319643717","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-64371-7_11","type":"book-chapter","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T06:54:30Z","timestamp":1510037670000},"page":"209-220","source":"Crossref","is-referenced-by-count":35,"title":["Epidemiology of Drug-Resistant Tuberculosis"],"prefix":"10.1007","author":[{"given":"Anna S.","family":"Dean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Zignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"e0149806","DOI":"10.1371\/journal.pone.0149806","volume":"11","author":"P Aia","year":"2016","unstructured":"Aia P, Kal M, Lavu E et al (2016) The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS One 11:e0149806. doi: 10.1371\/journal.pone.0149806","journal-title":"PLoS One"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/427940","volume":"40","author":"D Almeida","year":"2005","unstructured":"Almeida D, Rodrigues C, Ashavaid TF et al (2005) High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 40:881\u2013886","journal-title":"Clin Infect Dis"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.43.8.1866","volume":"43","author":"OJ Billington","year":"1999","unstructured":"Billington OJ, McHugh TD, Gillespie SH (1999) Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 43:1866\u20131869","journal-title":"Antimicrob Agents Chemother"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm1102","volume":"10","author":"SM Blower","year":"2004","unstructured":"Blower SM, Chou T (2004) Modeling the emergence of the \u201chot zones\u201d: tuberculosis and the amplification dynamics of drug resistance. Nat Med 10:1111\u20131116","journal-title":"Nat Med"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3201\/eid1009.040349","volume":"10","author":"MW Borgdorff","year":"2004","unstructured":"Borgdorff MW (2004) New measurable indicator for tuberculosis case detection. Emerg Infect Dis 10:1523\u20131528. doi: 10.3201\/eid1009.040349","journal-title":"Emerg Infect Dis"},{"key":"11_CR6","first-page":"869","volume":"12","author":"JA Caminero","year":"2008","unstructured":"Caminero JA (2008) Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation. Int J Tuberc Lung Dis 12:869\u2013877","journal-title":"Int J Tuberc Lung Dis"},{"key":"11_CR7","first-page":"585","volume":"40","author":"Centers for Disease Control (CDC)","year":"1991","unstructured":"Centers for Disease Control (CDC) (1991) Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons \u2013 Florida and New York, 1988\u20131991. MMWR Morb Mortal Wkly Rep 40:585\u2013591","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nm1110","volume":"10","author":"T Cohen","year":"2004","unstructured":"Cohen T, Murray M (2004) Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 10:1117\u20131121","journal-title":"Nat Med"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"e2363","DOI":"10.1371\/journal.pone.0002363","volume":"3","author":"T Cohen","year":"2008","unstructured":"Cohen T, Colijn C, Finklea B et al (2008) Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation study. PLoS One 3:e2363. doi: 10.1371\/journal.pone.0002363","journal-title":"PLoS One"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1471-2458-10-355","volume":"10","author":"T Cohen","year":"2010","unstructured":"Cohen T, Hedt BL, Pagano M (2010) Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study. BMC Public Health 10:355. doi: 10.1186\/1471-2458-10-355","journal-title":"BMC Public Health"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drup.2014.10.001","volume":"17","author":"T Cohen","year":"2014","unstructured":"Cohen T, Jenkins HE, Lu C et al (2014) On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data. Drug Resist Updat 17:105\u2013123. doi: 10.1016\/j.drup.2014.10.001","journal-title":"Drug Resist Updat"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/bmj.320.7232.440","volume":"320","author":"R Coninx","year":"2000","unstructured":"Coninx R, Maher D, Reyes H, Grzemska M (2000) Tuberculosis in prisons in countries with high prevalence. BMJ 320:440\u2013442","journal-title":"BMJ"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/infdis\/168.4.1052","volume":"168","author":"VG Coronado","year":"1993","unstructured":"Coronado VG, Beck-Sague CM, Hutton MD et al (1993) Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 168:1052\u20131055","journal-title":"J Infect Dis"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"e13901","DOI":"10.1371\/journal.pone.0013901","volume":"5","author":"HS Cox","year":"2010","unstructured":"Cox HS, McDermid C, Azevedo V et al (2010) Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 5:e13901. doi: 10.1371\/journal.pone.0013901","journal-title":"PLoS One"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/bmj.2.4588.1009","volume":"2","author":"J Crofton","year":"1948","unstructured":"Crofton J, Mitchison DA (1948) Streptomycin resistance in pulmonary tuberculosis. BMJ 2:1009\u20131015","journal-title":"BMJ"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1183\/09031936.00205413","volume":"44","author":"AS Dean","year":"2014","unstructured":"Dean AS, Zignol M, Falzon D et al (2014) HIV and multidrug-resistant tuberculosis: overlapping epidemics. Eur Respir J 44:251\u2013254. doi: 10.1183\/09031936.00205413","journal-title":"Eur Respir J"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.140102797","volume":"97","author":"C Dye","year":"2000","unstructured":"Dye C, Williams BG (2000) Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci U S A 97:8180\u20138185","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJM199206043262302","volume":"326","author":"BR Edlin","year":"1992","unstructured":"Edlin BR, Tokars JI, Grieco MH et al (1992) An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 326:1514\u20131521. doi: 10.1056\/NEJM199206043262302","journal-title":"N Engl J Med"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1056\/NEJM199302253280801","volume":"328","author":"TR Frieden","year":"1993","unstructured":"Frieden TR, Sterling T, Pablos-Mendez A et al (1993) The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 328:521\u2013526. doi: 10.1056\/NEJM199302253280801","journal-title":"N Engl J Med"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jama.1996.03540150031027","volume":"276","author":"TR Frieden","year":"1996","unstructured":"Frieden TR, Sherman LF, Maw KL et al (1996) A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276:1229\u20131235","journal-title":"JAMA"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1371\/journal.ppat.0020061","volume":"2","author":"S Gagneux","year":"2006","unstructured":"Gagneux S, Burgos MV, DeRiemer K et al (2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2:e61. doi: 10.1371\/journal.ppat.0020061","journal-title":"PLoS Pathog"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"NR Gandhi","year":"2006","unstructured":"Gandhi NR, Moll A, Sturm AW et al (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575\u20131580","journal-title":"Lancet"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/infdis\/jis631","volume":"207","author":"NR Gandhi","year":"2013","unstructured":"Gandhi NR, Weissman D, Moodley P et al (2013) Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 207:9\u201317. doi: 10.1093\/infdis\/jis631","journal-title":"J Infect Dis"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2471\/BLT.06.038331","volume":"85","author":"IY Gelmanova","year":"2007","unstructured":"Gelmanova IY, Keshavjee S, Golubchikova VT et al (2007) Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 85:703\u2013711","journal-title":"Bull World Health Organ"},{"key":"11_CR25","doi-asserted-by":"publisher","unstructured":"Guerra-Assun\u00e7\u00e3o JA, Crampin AC, RMGJ H et al (2015) Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area. Elife. doi: 10.7554\/eLife.05166","DOI":"10.7554\/eLife.05166"},{"key":"11_CR26","first-page":"1216","volume":"11","author":"C Habeenzu","year":"2007","unstructured":"Habeenzu C, Mitarai S, Lubasi D et al (2007) Tuberculosis and multidrug resistance in Zambian prisons, 2000\u20132001. Int J Tuberc Lung Dis 11:1216\u20131220","journal-title":"Int J Tuberc Lung Dis"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"e0153143","DOI":"10.1371\/journal.pone.0153143","volume":"11","author":"CL Heidebrecht","year":"2016","unstructured":"Heidebrecht CL, Podewils LJ, Pym A et al (2016) Assessing loval risk of rifampicin-resistant tuberculosis in KwaZulu-Natal, South Africa using lot quality assurance sampling. PLoS One 11:e0153143","journal-title":"PLoS One"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1183\/09031936.00111812","volume":"42","author":"HE Jenkins","year":"2013","unstructured":"Jenkins HE, Plesca V, Ciobanu A et al (2013) Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J 42:1291\u20131301. doi: 10.1183\/09031936.00111812","journal-title":"Eur Respir J"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"20743","DOI":"10.2807\/1560-7917.ES2014.19.11.20743","volume":"19","author":"HE Jenkins","year":"2014","unstructured":"Jenkins HE, Gegia M, Furin J et al (2014a) Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011. Euro Surveill 19:20743","journal-title":"Euro Surveill"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0140-6736(14)60195-1","volume":"383","author":"HE Jenkins","year":"2014","unstructured":"Jenkins HE, Tolman AW, Yuen CM et al (2014b) Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 383:1572\u20131579. doi: 10.1016\/S0140-6736(14)60195-1","journal-title":"Lancet"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","volume":"3","author":"EA Kendall","year":"2015","unstructured":"Kendall EA, Fofana MO, Dowdy DW (2015) Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Lancet Respir Med 3:963\u2013972. doi: 10.1016\/S2213-2600(15)00458-0","journal-title":"Lancet Respir Med"},{"key":"11_CR32","first-page":"451","volume":"3","author":"ME Kimerling","year":"1999","unstructured":"Kimerling ME, Kluge H, Vezhnina N et al (1999) Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis 3:451\u2013453","journal-title":"Int J Tuberc Lung Dis"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3201\/\/EID1903.120246","volume":"19","author":"M Klopper","year":"2013","unstructured":"Klopper M, Warren RM, Hayes C et al (2013) Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis 19:449\u2013455. doi: 10.3201\/\/EID1903.120246","journal-title":"Emerg Infect Dis"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12889-015-1614-8","volume":"15","author":"D Lukoye","year":"2015","unstructured":"Lukoye D, Ssengooba W, Musisi K et al (2015) Variation and risk factors of drug resistant tuberculosis in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health 15:291. doi: 10.1186\/s12889-015-1614-8","journal-title":"BMC Public Health"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"e82235","DOI":"10.1371\/journal.pone.0082235","volume":"9","author":"YM Mesfin","year":"2014","unstructured":"Mesfin YM, Hailemariam D, Biadglign S, Kibret KT (2014) Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS One 9:e82235. doi: 10.1371\/journal.pone.0082235","journal-title":"PLoS One"},{"key":"11_CR36","first-page":"99","volume":"12","author":"CK Mlambo","year":"2008","unstructured":"Mlambo CK, Warren RM, Poswa X et al (2008) Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 12:99\u2013104","journal-title":"Int J Tuberc Lung Dis"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0140-6736(91)92559-K","volume":"337","author":"L Monno","year":"1991","unstructured":"Monno L, Angarano G, Carbonara S et al (1991) Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet 337:852","journal-title":"Lancet"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3201\/eid1606.091844","volume":"16","author":"Y Murase","year":"2010","unstructured":"Murase Y, Maeda S, Yamada H et al (2010) Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 16:948\u2013954. doi: 10.3201\/eid1606.091844","journal-title":"Emerg Infect Dis"},{"key":"11_CR39","first-page":"1233","volume":"14","author":"E Nardell","year":"2010","unstructured":"Nardell E, Dharmadhikari A (2010) Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 14:1233\u20131243","journal-title":"Int J Tuberc Lung Dis"},{"key":"11_CR40","first-page":"427","volume":"14","author":"A Nodieva","year":"2010","unstructured":"Nodieva A, Jansone I, Broka L et al (2010) Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 14:427\u2013433","journal-title":"Int J Tuberc Lung Dis"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1056\/NEJM199806043382301","volume":"338","author":"A Pablos-M\u00e9ndez","year":"1998","unstructured":"Pablos-M\u00e9ndez A, Raviglione MC, Laszlo A et al (1998) Global surveillance for antituberculosis-drug resistance, 1994\u20131997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 338:1641\u20131649. doi: 10.1056\/NEJM199806043382301","journal-title":"N Engl J Med"},{"key":"11_CR42","first-page":"377","volume":"120","author":"CN Paramasivan","year":"2004","unstructured":"Paramasivan CN, Venkataraman P (2004) Drug resistance in tuberculosis in India. Indian J Med Res 120:377\u2013386","journal-title":"Indian J Med Res"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/jac\/dkp452","volume":"65","author":"J Perdigao","year":"2010","unstructured":"Perdigao J, Macedo R, Malaquias A et al (2010) Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. J Antimicrob Chemother 65:224\u2013227. doi: 10.1093\/jac\/dkp452","journal-title":"J Antimicrob Chemother"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"e008273","DOI":"10.1136\/bmjopen-2015-008273","volume":"5","author":"M Rifat","year":"2015","unstructured":"Rifat M, Hall J, Oldmeadow C et al (2015) Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open 5:e008273. doi: 10.1136\/bmjopen-2015-008273","journal-title":"BMJ Open"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1128\/JCM.01489-06","volume":"45","author":"L Rigouts","year":"2007","unstructured":"Rigouts L, Nolasco O, de Rijk P et al (2007) Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 45:252\u2013254. doi: 10.1128\/JCM.01489-06","journal-title":"J Clin Microbiol"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"e1001387","DOI":"10.1371\/journal.pmed.1001387","volume":"10","author":"A Roetzer","year":"2013","unstructured":"Roetzer A, Diel R, Kohl TA et al (2013) Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 10:e1001387. doi: 10.1371\/journal.pmed.1001387","journal-title":"PLoS Med"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7196\/samj.6182","volume":"103","author":"K Schnippel","year":"2013","unstructured":"Schnippel K, Meyer-Rath G, Long L et al (2013) Diagnosing Xpert MTB\/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J 103:101\u2013106. doi: 10.7196\/samj.6182","journal-title":"S Afr Med J"},{"issue":"Suppl 3","key":"11_CR48","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1086\/651496","volume":"50","author":"SV Shenoi","year":"2010","unstructured":"Shenoi SV, Escombe AR, Friedland G (2010) Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts. Clin Infect Dis 50(Suppl 3):S231\u2013S237. doi: 10.1086\/651496","journal-title":"Clin Infect Dis"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"13280","DOI":"10.1073\/pnas.0801200105","volume":"105","author":"D Stuckler","year":"2008","unstructured":"Stuckler D, Basu S, Mckee M, King L (2008) Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. P Natl Acad Sci USA 105:13280\u201313285. doi: 10.1073\/pnas.0801200105","journal-title":"P Natl Acad Sci USA"},{"key":"11_CR50","doi-asserted-by":"crossref","unstructured":"Ulmasova D, Uzakova G, Tillyashayhov M et al (2013) Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Euro Surveill. doi: 20609 [pii]","DOI":"10.2807\/1560-7917.ES2013.18.42.20609"},{"key":"11_CR51","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K et al (2015) WHO\u2019s new end TB strategy. Lancet 385:1799\u20131801. doi: 10.1016\/S0140-6736(15)60570-0","journal-title":"Lancet"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1183\/09031936.00131014","volume":"45","author":"S Hof van den","year":"2015","unstructured":"van den Hof S, Tursynbayeva A, Abildaev T et al (2015) HIV and multidrug-resistant tuberculosis: overlapping risk factors. Eur Respir J 45:567\u2013569. doi: 10.1183\/09031936.00131014","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"11_CR53","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1086\/518665","volume":"196","author":"CD Wells","year":"2007","unstructured":"Wells CD, Cegielski JP, Nelson LJ et al (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196(Suppl 1):S86\u2013107. doi: 10.1086\/518665","journal-title":"J Infect Dis"},{"key":"11_CR54","unstructured":"World Health Organization (2013) The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. Interim policy guidance. WHO\/HTM\/TB\/2013.6. Geneva"},{"key":"11_CR55","unstructured":"World Health Organization (2014a) Drug-resistant TB \u2013 surveillance and response. Supplement to global tuberculosis report 2014. WHO\/HQ\/TB\/2014.12. Geneva"},{"key":"11_CR56","unstructured":"World Health Organization (2014b) Global tuberculosis report 2014. WHO\/HTM\/TB\/2014.08. Geneva"},{"key":"11_CR57","unstructured":"World Health Organization (2014c) Xpert MTB\/RIF implementation manual. Technical and operational \u201chow-to\u201d: practical considerations"},{"key":"11_CR58","unstructured":"World Health Organization (2014d) The use of delamanid in the treatment of multidrug-resistant tuberculosis. WHO\/HTM\/TB2014.23. Geneva"},{"key":"11_CR59","unstructured":"World Health Organization (2016) Global tuberculosis report 2015. Geneva"},{"key":"11_CR60","unstructured":"World Health Organization WHO End TB Strategy. http:\/\/www.who.int\/tb\/post2015_strategy\/en"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/infdis\/jiv387","volume":"213","author":"JL Zelner","year":"2016","unstructured":"Zelner JL, Murray MB, Becerra MC et al (2016) Identifying hotspots of multidrug-resistant tuberculosis transmission using spatial and molecular genetic data. J Infect Dis 213:287\u2013294. doi: 10.1093\/infdis\/jiv387","journal-title":"J Infect Dis"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L et al (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366:2161\u20132170. doi: 10.1056\/NEJMoa1108789","journal-title":"N Engl J Med"},{"key":"11_CR63","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1183\/09031936.00175812","volume":"42","author":"M Zignol","year":"2013","unstructured":"Zignol M, Sismanidis C, Falzon D et al (2013) Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J 42:701\u2013707. doi: 10.1183\/09031936.00175812","journal-title":"Eur Respir J"},{"key":"11_CR64","unstructured":"Zignol M, Dean A, Falzon D, et al (2016) Twenty years of global surveillance of anti-tuberculosis drug resistance: key achievements and findings, remaining challenges, future direction"}],"container-title":["Advances in Experimental Medicine and Biology","Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-64371-7_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T18:40:13Z","timestamp":1570300813000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-64371-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319643694","9783319643717"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-64371-7_11","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}